We observed aberrant expression of HNF4A-AS1 in various liver diseases, with elevated expression in NAFLD and cirrhosis, and decreased expression in HCC (Figure S1H). This evidence concerns the gene HNF4A and metabolic dysfunction-associated steatotic liver disease.